Effects of Long-Term Treatment with Atorvastatin and Rosuaastatin on Active Avoidance Test in Intact Rats

1. van der Most PJ, Dolga A,Nijholt I, Luiten P, Eisel U. Statins: Mechanisms of neuroprotection. Prog Neurobiol. 2009;88(l):64-75.10.1016/j.pneurobio.2009.02.00219428962Search in Google Scholar

2. Masse I, Beordet R, Deplanque D, A1K, Richard F, Libersa et al. Lipid lowering drugs are associated with a slower cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2005; 76(12): 1624-9.10.1136/jnnp.2005.063388173946616291883Search in Google Scholar

3. Jick H, Zomberg GL, Jick S, Seshadri S, Drachman DA. Statins and the risk of dementia, The Lancet. 2000;356:1627-31.Search in Google Scholar

4. Bemick C, Katz R, Smith NL, Rapp S, Bhadelia R, Carlson M, et al. Statins and cognitive function in the elderly: the Cardiovascular Health Study. Neurology. 2005;65(9): 1388-94.10.1212/01.wnl.0000182897.18229.ec16275825Search in Google Scholar

5. Parle M, Singh N. Reversal of memory deficits by Atorvastatin and Simvastatin in Rats. Yakugaku Zasshi. 2007; 127(7): 1125-37.10.1248/yakushi.127.112517603272Search in Google Scholar

6. Evans MA, Golomb BA, Statin-associated adverse cognitive effects: survey results from 171 patients. Pharmacotherapy. 2009;29(7):800-l 1.10.1592/phco.29.7.80019558254Search in Google Scholar

7. Padala KP, Padala PR, Potter JF, Simvastatin-induced decline in cognition, Ann Pharmacother. 2006;40( 10): 1880-3.10.1345/aph.1H01416940411Search in Google Scholar

8. Kalonia H, Kumar P, Kumar A. Comparative neuroprotective profile of statins in quinolinic acid induced neurotoxicity in rats. Behav Brain Res. 2011;216(1): 220-8.10.1016/j.bbr.2010.07.04020696189Search in Google Scholar

9. Wang H, Lynch JR, Song P, Yang HJ, Yates RB, Mace B, et al. Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration and improve cerebral blood flow after experimental traumatic brain injury. Exp Neurol. 2007;206(1): 56-69.10.1016/j.expneurol.2007.03.03117521631Search in Google Scholar

10. Ucak A, Onan B, Guler A, Sahin MA, KihqkayaO, Oztaș E, et al. Rosuvastatin, a new generation 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, reduces ischemia/reperfesion-induced spinal cord tissue injury in rats. Ann Vase Surg. 2011;25(5):686-95.10.1016/j.avsg.2011.02.02421724106Search in Google Scholar

11. Baytan SH, Alkanat M, Okuyan M, Ekinci M, Gedikli E, Ozeren M, et al. Simvastatin impairs spatial memory in rats at a specific dose level. Tohoku J Exp Med. 2008;214(4):341 -9.10.1620/tjem.214.34118441510Search in Google Scholar

12. Baytan SH, Alkatan M, Ozeren M, Ekinci M, Akgun A. Fluvastatin alters psychomotor performance and daily activity but not the spatial memory in rats. Tohoku J Exp Med. 2006,209(4), 311-20.Search in Google Scholar

13. Douma TN, Borre Y, Hendriksen H, Olivier B, Oosting RS. Simvastatin improves learning and memory in control but not in olfactory bulbectomized rats. Psychopharmacology. 2011 ;216(4):537-44.10.1007/s00213-011-2245-0Search in Google Scholar

14. Vaughan CJ. Prevention of stroke and dementia with statins: effects beyond lipid lowering. Am J Cardiol.2003;91(4A):23B-29B.10.1016/S0002-9149(02)03270-8Search in Google Scholar

15. Wang Q, Zengin A, Deng C, Li Y, Newell KA, Yang GY, et al. High dose of simvastatin induces hyperlocomotive and anxiolytic-like activities: the association with the upregulation of NMDA receptor binding in the rat brain. Exp Neurol. 2009;216( 1): 132-8.10.1016/j.expneurol.2008.11.016Search in Google Scholar

16. Magnusson KR, Cotman C W. Effects of aging on NMDAnand MK801 binding sites in mice. Brain Res. 1993 ;604( 1 -2) :334-7.10.1016/0006-8993(93)90386-2Search in Google Scholar

17. Malenka RC, Nicoll RA. Long-term potentiation-a decade of progress? Science 1999; 285(5435): 1870-4. Search in Google Scholar